A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients-Reference-Cited by-同舟云学术

A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients

Published:2017-08-03 Issue:46 Volume:8 Page:81441-81454
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Byers Lauren Averett¹,Horn Leora²,Ghandi Jitendra³,Kloecker Goetz⁴,Owonikoko Taofeek⁵,Waqar Saiama Naheed⁶,Krzakowski Maciej⁷,Cardnell Robert J.¹,Fujimoto Junya¹,Taverna Pietro⁸,Azab Mohammad⁸,Camidge David Ross⁹

Affiliation:

1. University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA

2. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA

3. Associates in Oncology and Hematology, Chattanooga, TN, USA

4. James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA

5. Winship Cancer Institute, Emory University, Atlanta, GA, USA

6. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA

7. Centrum Onkologii-Instytut Im. M. Skłodowskiej-Curie w Warszawie, Warszawa, Poland

8. Astex Pharmaceuticals, Inc. Pleasanton, CA, USA

9. Anschutz Cancer Pavilion, University of Colorado Cancer Center, Aurora, CO, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actionable Driver Events in Small Cell Lung Cancer;International Journal of Molecular Sciences;2023-12-20

2. Current and Emerging Treatment Options for Patients With Relapsed Small-cell Lung Carcinoma: A Systematic Literature Review;Clinical Lung Cancer;2023-05

3. Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead;OncoTargets and Therapy;2022-12

4. Construction and validation of a novel Ferroptosis-related gene signature predictive model in rectal Cancer;BMC Genomics;2022-11-22

5. βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells;Cancer Medicine;2022-08-10